Hepion Pharmaceuticals, Inc.
NASDAQ:HEPA
0.3221 (USD) • At close April 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -13.192 | -48.926 | -42.2 | -32.722 | -20.354 | -7.037 | -9.449 | -15.022 | -14.891 | -16.999 | -14.348 | -5.281 | -0.001 |
| Depreciation & Amortization
| 0.031 | 0.067 | 0.077 | 0.086 | 0.035 | 0.027 | 0.019 | 0.022 | 0.028 | 0.022 | 0.016 | 0.001 | 0 |
| Deferred Income Tax
| 0 | -0.409 | 1.871 | 0 | 0.006 | 0.048 | -0.536 | -0.373 | -4.225 | 0 | 0.388 | 0 | 0 |
| Stock Based Compensation
| 0.792 | 1.34 | 2.553 | 4.669 | 2.379 | 0.066 | 0.235 | 0.002 | 1.7 | 0.902 | 2.118 | 0.195 | 0 |
| Change In Working Capital
| -2.683 | 2.971 | 3.153 | -5.567 | 1.629 | -0.826 | -0.97 | -0.019 | -1.841 | 3.327 | 0.953 | 0.125 | 0 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 0.303 | 2.246 | -1.068 | 3.039 | -0.317 | -0.898 | -0.111 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -2.683 | 2.668 | 0.907 | -4.499 | -1.41 | -0.509 | -0.97 | 0.092 | 0 | 3.327 | 0.953 | -0 | 0 |
| Other Non Cash Items
| -3.163 | 4.068 | -0.415 | 2.31 | 0.14 | 0.157 | -4.944 | 7.338 | -4.169 | -3.807 | 1.588 | 3.596 | 0.001 |
| Operating Cash Flow
| -18.216 | -40.889 | -34.961 | -31.224 | -16.165 | -7.565 | -15.646 | -8.209 | -19.172 | -16.555 | -9.673 | -1.363 | -0 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| 0 | -0.014 | -0.016 | -0.13 | -0.088 | -0.051 | 0 | -0 | -0.015 | -0.007 | -0.083 | -0.016 | 0 |
| Acquisitions Net
| 0 | 0 | 0.002 | 0 | 0.002 | 0 | 0.001 | 0 | 0 | -0.496 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -0.6 | -0.014 | -0.014 | -0.13 | -0.086 | -0.051 | 0.001 | -0 | -0.015 | -0.502 | -0.083 | -0.016 | 0 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 0 | 0 | 0 | -0.177 | 0.177 | -1.119 | 1.331 | 0 | -0.01 | 0 | 0 | -0.1 | 0 |
| Common Stock Issued
| 2.5 | 4.495 | 17.863 | 82.154 | 42.866 | 7.684 | 1.635 | 1.181 | 24.66 | 19.898 | 12.501 | 3.225 | 0 |
| Common Stock Repurchased
| 0 | 0 | -21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 1.85 | 4.495 | -5.138 | 0 | 0.012 | 12.143 | 9.557 | 11.897 | 0.116 | 19.898 | 12.501 | -0.015 | 0.001 |
| Financing Cash Flow
| 4.35 | 4.495 | -5.138 | 81.977 | 43.055 | 18.707 | 12.524 | 1.181 | 24.766 | 19.898 | 12.501 | 3.11 | 0.001 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0.087 | 0.005 | -0.047 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -14.379 | -36.403 | -40.16 | 50.622 | 26.804 | 11.091 | -3.122 | -1.45 | 5.579 | 2.841 | 2.745 | 1.731 | 0.001 |
| Cash At End Of Period
| 0.406 | 14.786 | 51.189 | 91.349 | 40.727 | 13.923 | 2.832 | 5.954 | 12.983 | 7.404 | 4.563 | 1.818 | 0.001 |